Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 LivaNova PLC (Exact name of registrant as specified in its ...

LivaNova PLC (NASDAQ:LIVN) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development & IT Bill Cozy - Chairman and Interim Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Stephanie Bolton - President, Global Epilepsy Conference Call Participants Rick Wise - Stiefel Mike Polark - Wolfe Research Adam Maeder - Piper Sandler Matt Taylor - Jefferies Mike Matson - Needham & Company Anthony Petrone - Mizuho Grou ...

Health innovation that matters 2 This report may contain references to our proprietary intellectual property, including among others: These trademarks and trade names are the property of LivaNova or the property of our consolidated subsidiaries and are protected under applicable intellectual property laws. Solely for convenience, our trademarks and tradenames referred to in this Annual Report on Form 10-K may appear without the ™ symbol, but such references are not intended to indicate in any way that we wi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 LivaNova PLC (Exact name of registrant as specified in its char ...

LivaNova PLC (NASDAQ:LIVN) Q2 2023 Earnings Conference Call July 26, 2023 8:00 AM ET Company Participants Matthew Dodds - SVP, Corporate Development & IT William Kozy - Chairman & Interim CEO Alex Shvartsburg - CFO Stephanie Bolton - President, Global Epilepsy Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company Matthew Miksic - Barclays Bank Michael Polark - Wolfe Research Michael Matson - Needham & Company David Rescott - Robert W. Baird & Co. Matthew Taylor - Jefferies Adam Maeder - P ...

Kits used for cardiac procedures grew year over year, offset by respiratory case declines and product mix. | --- | --- | --- | --- | |---------------------------------------------------------------------|-------|---------|----------| | Adjusted Free Cash Flow Reconciliation ($M) 1Q 2023 | | 2Q 2023 | 2023 YTD | | Net cash provided by operating activities | $20.8 | $(17.9) | $2.8 | | Less: Purchases of plant, property and equipment (7.7) (5.7) (13.3) | | | | | Less: Cash received from tax stimulus (9.9) — (9 ...

LivaNova PLC (NASDAQ:LIVN) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development William Kozy - Chairman & Interim Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Michael Polark - Wolfe Research Matthew Taylor - Jefferies Adam Maeder - Piper Sandler Mike Matson - Needham & Company Operator Good day ladies and gentlemen and welcome to the LivaNova ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 LivaNova PLC (Exact name of registrant as specified in its cha ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number: 001-37599 LivaNova PLC (Exact name of registrant as specified in its charter) England and Wales ................... 98-126815 ...

LivaNova PLC (NASDAQ:LIVN) Q4 2022 Results Earnings Conference Call February 22, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Michael Polark - Wolfe Research Matthew Taylor - Jefferies LLC Adam Maeder - Piper Sandler Mike Matson - Needham & Company, LLC Matt Miksic - Barclays Capital Operator Good day, ladies and g ...